Azacitidine
2024-0371
Phase 1 small_molecule active
Quick answer
Azacitidine for Myelodysplastic Syndrome is a Phase 1 program (small_molecule) at PMV Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PMV Pharmaceuticals
- Indication
- Myelodysplastic Syndrome
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active